Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine

Objective:The aim was to assess the prognostic variables in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer patients receiving lapatinib plus capecitabine.Materials and Methods:Retrospective data on HER2-positive metastatic breast cancer patients who received lapati...

Full description

Bibliographic Details
Main Authors: İzzet Doğan, Nail Paksoy, Naziye Ak, Sezai Vatansever, Pınar Saip, Adnan Aydıner
Format: Article
Language:English
Published: Galenos Publishing House 2023-04-01
Series:European Journal of Breast Health
Subjects:
Online Access: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/prognostic-factors-nfluencing-progression-free-sur/59075